Oka H, Kurata A, Kawano N, Saegusa H, Kobayashi I, Ohmomo T, Miyasaka Y, Fujii K
Department of Neurosurgery, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
J Neurooncol. 1998 Oct;40(1):67-71. doi: 10.1023/a:1006196420398.
We evaluated the clinical significance of preoperative superselective embolization for skull-base meningiomas. The subjects consisted of 20 patients with skull-base meningiomas, and were classified into a preoperative embolized group and a non-embolized group. The volume of blood transfused during the operation, the length of the operative procedure and the neurological outcome were compared between the two groups. The results showed that, in tumors smaller than 6 cm, the blood lost during the operation was significantly less in the embolized group. In tumors larger than 6 cm, there was not difference in blood lost, perhaps because larger meningiomas tend to have tiny blood vessels that are unsuitable for preoperative embolization. There was no difference in the length of the operation between the two groups. The embolized group tended to show a better clinical outcome than the non-embolized group.
我们评估了术前超选择性栓塞治疗颅底脑膜瘤的临床意义。研究对象为20例颅底脑膜瘤患者,分为术前栓塞组和未栓塞组。比较了两组手术期间的输血量、手术时长和神经功能结局。结果显示,对于直径小于6 cm的肿瘤,栓塞组术中失血量明显较少。对于直径大于6 cm的肿瘤,两组失血量无差异,这可能是因为较大的脑膜瘤往往有细小血管,不适合术前栓塞。两组手术时长无差异。栓塞组的临床结局往往优于未栓塞组。